Related Experiment Videos
Statins in primary biliary cirrhosis: are they safe?
Murad Abu Rajab1, Marshall M Kaplan
1Division of Gastroenterology, Department of Medicine, Tufts Medical Center, Boston, MA 02111, USA.
Digestive Diseases and Sciences
|October 2, 2009
Summary
Statins are safe for primary biliary cirrhosis (PBC) patients with high cholesterol. This study found no increase in liver enzymes and a significant decrease in cholesterol levels, indicating good tolerability and efficacy.
Area of Science:
- Hepatology
- Cardiology
- Pharmacology
Background:
- Primary biliary cirrhosis (PBC) patients often have elevated cholesterol levels.
- A subset of PBC patients (approx. 10%) exhibit dyslipidemia, potentially benefiting from lipid-lowering therapy.
- Concerns exist regarding statin use in patients with pre-existing liver conditions.
Purpose of the Study:
- To evaluate the safety and efficacy of statins in patients with primary biliary cirrhosis.
- To assess the impact of statins on liver enzymes and cholesterol levels in PBC patients.
Main Methods:
- Retrospective review of 603 PBC patients seen between 1996 and 2006.
- Analysis of data from 58 patients treated with statins and 5 with ezetimibe.
- Monitoring of alanine aminotransferase (ALT) levels at 3-month intervals during treatment.
Main Results:
- Statins were well-tolerated, with no reported muscle pain or weakness.
- No significant increase in ALT levels was observed; levels normalized or remained stable.
- Serum cholesterol levels decreased by approximately 30% (P < 0.01).
- Ezetimibe was also found to be well-tolerated.
Conclusions:
- Statins are a safe treatment option for primary biliary cirrhosis patients requiring cholesterol management.
- Lipid-lowering therapy with statins can effectively reduce cholesterol levels in PBC patients without adversely affecting liver function.
Related Concept Videos
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
01:26Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
01:25Blood Studies for Cardiovascular System III: Serum Lipid Profile
Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
01:20Cholecystitis
Cholecystitis is inflammation of the gallbladder, most commonly caused by obstruction of the cystic duct. This blockage prevents bile from draining, leading to gallbladder distension, inflammation, and potentially serious complications. This condition may present acutely or chronically and can happen with or without gallstones.EtiologyAbout 95% of cholecystitis cases are calculous, caused by gallstones blocking the cystic duct, leading to bile accumulation and inflammation of the gallbladder...